Monograph
V08BA01 - Barium Sulfate with Suspending Agents |
Not porphyrinogenic |
NP |
Rationale
Barium sulfate is not absorbded, and is extreted unchanged through the gastrointestinal tract.
Chemical description
Practically insoluble salt of barium.
Therapeutic characteristics
Barium sulfate is used as a radiographic contrast medium for X-ray examination of the gastrointestinal tract involving single- or double-contrast techniques or computed tomography. Administered orally or as an enema.
Hepatic exposure
Not significant.
Metabolism and pharmacokinetics
Barium sulfate travels unchanged through the gastro intestinal tract.
IPNet drug reports
No.
References
| # | Citation details | PMID |
|---|---|---|
| * | Drug reference publications | |
| 1. | Sweetman SC, editor. Martindale: The complete drug reference. Barium Sulfate. Pharmaceutical Press 2009.
|
|
| * | Summary of Product Characteristics | |
| 2. | Norwegian medicines agency. Summary of Product Characteristics (SPC). Mixobar Colon.
|
|
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
United Kingdom
Norway
Poland
Luxembourg© NAPOS 2024